| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | insulin lispro (Liumjev®) |
| Formulation | 100 units/ml and 200 units/ml solution for injection |
| Reference number | 3703 |
| Indication | Treatment of diabetes mellitus in adults |
| Company | Eli Lilly & Co Ltd |
| BNF chapter | Endocrine system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 22/04/2020 |